Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.

Falchetti A.

F1000Res. 2017 Jan 24;6. pii: F1000 Faculty Rev-73. doi: 10.12688/f1000research.7230.1. eCollection 2017. Review.

2.

MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.

Schernthaner-Reiter MH, Trivellin G, Stratakis CA.

Neuroendocrinology. 2016;103(1):18-31. doi: 10.1159/000371819. Epub 2015 Jan 9. Review.

3.

FBP1 Is an Interacting Partner of Menin.

Zaman S, Sukhodolets K, Wang P, Qin J, Levens D, Agarwal SK, Marx SJ.

Int J Endocrinol. 2014;2014:535401. doi: 10.1155/2014/535401. Epub 2014 Jul 14.

4.
5.
6.

Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Zhou Y, Zhang X, Klibanski A.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):16-33. doi: 10.1016/j.mce.2013.09.006. Epub 2013 Sep 11. Review.

7.

Decoding information in cell shape.

Rangamani P, Lipshtat A, Azeloglu EU, Calizo RC, Hu M, Ghassemi S, Hone J, Scarlata S, Neves SR, Iyengar R.

Cell. 2013 Sep 12;154(6):1356-69. doi: 10.1016/j.cell.2013.08.026.

8.

Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Thakker RV.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15. doi: 10.1016/j.mce.2013.08.002. Epub 2013 Aug 8. Review.

9.

Menin: a scaffold protein that controls gene expression and cell signaling.

Matkar S, Thiel A, Hua X.

Trends Biochem Sci. 2013 Aug;38(8):394-402. doi: 10.1016/j.tibs.2013.05.005. Epub 2013 Jul 10. Review.

10.

Interplay between menin and K-Ras in regulating lung adenocarcinoma.

Wu Y, Feng ZJ, Gao SB, Matkar S, Xu B, Duan HB, Lin X, Li SH, Hua X, Jin GH.

J Biol Chem. 2012 Nov 16;287(47):40003-11. doi: 10.1074/jbc.M112.382416. Epub 2012 Oct 1.

11.

Expression and subcellular localization of menin in human cancer cells.

Ren F, Xu HW, Hu Y, Yan SH, Wang F, Su BW, Zhao Q.

Exp Ther Med. 2012 Jun;3(6):1087-1091. Epub 2012 Mar 29.

12.

MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Walls GV, Lemos MC, Javid M, Bazan-Peregrino M, Jeyabalan J, Reed AA, Harding B, Tyler DJ, Stuckey DJ, Piret S, Christie PT, Ansorge O, Clarke K, Seymour L, Thakker RV.

Cancer Res. 2012 Oct 1;72(19):5060-8. doi: 10.1158/0008-5472.CAN-12-1821. Epub 2012 Aug 21.

13.
14.

Menin represses tumorigenesis via repressing cell proliferation.

Wu T, Hua X.

Am J Cancer Res. 2011;1(6):726-39. Epub 2011 May 16.

15.

Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Piecha G, Chudek J, Więcek A.

Int J Endocrinol. 2010;2010:928383. doi: 10.1155/2010/928383. Epub 2011 Jan 17.

16.

Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells.

Yan J, Yang Y, Zhang H, King C, Kan HM, Cai Y, Yuan CX, Bloom GS, Hua X.

Oncogene. 2009 Feb 19;28(7):973-82. doi: 10.1038/onc.2008.435. Epub 2008 Dec 15.

18.
19.

In search of tumor suppressing functions of menin.

Yang Y, Hua X.

Mol Cell Endocrinol. 2007 Feb;265-266:34-41. Epub 2007 Jan 11. Review.

20.

Multiple endocrine neoplasia type 1.

Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML.

Orphanet J Rare Dis. 2006 Oct 2;1:38. Review.

Supplemental Content

Support Center